2005 Annual Report

Financial Summary

Fiscal Years 2005 and 2004

Consolidated Balance Sheets

Assets
(in thousands of dollars)		 June 30, 2005 June 30, 2004
Cash and cash equivalents $       9,981 $       6,681
Grants and contracts receivable 12,317 11,924
Other receivables 22,749 27,327
Investments, at market 125,553 111,273
Trustee-held funds 12,614 14,347
Land, buildings and equipment,
  net of accumulated depreciation
  of $175,873 and $154,714		 308,269 317,201
Deferred financing costs, net 12,804 13,343
Total assets $ 504,287 $ 502,096
 
Liabilities and net assets
(in thousands of dollars)		 June 30, 2005 June 30, 2004
Accounts payable and accrued liabilities $    42,120 $    37,738
Accrued payroll and related costs 18,441 15,218
Long-term debt and payable to government agencies 297,201 306,539
Deferred revenue 6,506 7,351
Total liabilities 364,268 366,846
 
Unrestricted net assets 105,979 100,982
Temporarily restricted net assets 22,808 22,728
Permanently restricted net assets 11,232 11,540
Total net assets 140,019 135,250

Total liabilities and net assets

 $ 504,287 $ 502,096

 

 

Every private gift plays an essential role in helping to save lives, including:

  • Research advances in prevention, early detection and treatment of cancer
  • Breakthroughs for patients with leukemia, lymphoma, breast cancer, ovarian cancer, prostate cancer, AIDS and other life-threatening diseases
  • Recruitment of the world's top scientists and physicians; lab facilities for these new reseachers
  • Specialized technology that accelerates the pace of lifesaving breakthroughs
  • The nation's top cancer-prevention research center, which empowers people worldwide with knowledge to stop cancer before it starts
  • Housing, food and transportation assistance for patients and family members
     
    * The Northwest regional office of the National Cancer Institute's Cancer Information Service, which provides the latest cancer information to the public (1-800-4-CANCER or www.cancer.gov)

 

Fiscal year 2005 contributions received (in thousands of dollars)

Consolidated Statements of Activity

Revenues and other support
(in thousands of dollars)		 June 30, 2005 June 30, 2004
Research grants and contracts $ 238,429 $ 217,297
Contributions, net of cost of special events of $1,077 and $938 32,084 29,789
Investment income and realized gains and losses 10,226 15,339
Other income 25,813 24,054

Total revenues

 $ 306,552 $ 286,479
 
 
Expenses
(in thousands of dollars)		 June 30, 2005 June 30, 2004
Program services—research $ 228,043 $ 203,410
Management and general 61,738 59,313
Fund raising 4,557 4,245
Total expenses $ 294,338 $ 266,968
 
Change in net assets from operations 12,214 19,511
Changes in net assets from financing activities and extraordinary gain (7,445) 22,204
Total increase (decrease) in net assets 4,769 41,715
Net assets balance at beginning of year 135,250 93,535
Net assets balance at end of year $140,019 $135,250



 

Major direct sources of support (in millions of dollars)

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.